Naproxen Sodium And Diphenhydramine Hcl Tablet, Film Coated
Product Images NDC 69238-1422

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium And Diphenhydramine Hcl (NDC 69238-1422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

160 (Naproxen Sodium And Diphenhydramine HCl Tablets 1)

Packaging label for Naproxen Sodium and Diphenhydramine HCl Tablets, 220 mg/25 mg strength, film-coated tablets by Amneal Pharmaceuticals NY LLC. The label indicates this product contains 160 tablets. It is identified as a pain reliever (NSAID) and nighttime sleep-aid with the NDC code 69238-1422.*

FDA Label Image

160 (Naproxen Sodium And Diphenhydramine HCl Tablets 2)

Naproxen Sodium and Diphenhydramine HCl Tablets 220 mg/25 mg film-coated tablets packaging label. The label includes active ingredients naproxen sodium 220 mg and diphenhydramine hydrochloride 25 mg, and Drug Facts with uses, warnings, directions, and inactive ingredients. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Package indicates 160 tablets and features a barcode and a blister pack image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.